RhumbLine Advisers’s NxStage Medical Inc. NXTM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-92,310
| Closed | -$2.64M | – | 2981 |
|
|
2018
Q4 | $2.64M | Buy |
92,310
+29,191
| +46% | +$829K | 0.01% | 1478 |
|
|
2018
Q3 | $1.76M | Sell |
63,119
-4,331
| -6% | -$122K | ﹤0.01% | 1722 |
|
|
2018
Q2 | $1.88M | Buy |
67,450
+2,250
| +3% | +$60.3K | ﹤0.01% | 1709 |
|
|
2018
Q1 | $1.62M | Sell |
65,200
-2,105
| -3% | -$51.2K | ﹤0.01% | 1717 |
|
|
2017
Q4 | $1.63M | Sell |
67,305
-11,414
| -14% | -$301K | ﹤0.01% | 1737 |
|
|
2017
Q3 | $2.17M | Buy |
78,719
+1,335
| +2% | +$35.6K | ﹤0.01% | 1558 |
|
|
2017
Q2 | $1.94M | Buy |
77,384
+115
| +0.1% | +$2.85K | ﹤0.01% | 1596 |
|
|
2017
Q1 | $2.07M | Buy |
77,269
+2,497
| +3% | +$69K | ﹤0.01% | 1528 |
|
|
2016
Q4 | $1.96M | Buy |
74,772
+3,181
| +4% | +$78.7K | 0.01% | 1466 |
|
|
2016
Q3 | $1.79M | Buy |
71,591
+1,385
| +2% | +$32.3K | ﹤0.01% | 1485 |
|
|
2016
Q2 | $1.52M | Buy |
70,206
+2,040
| +3% | +$36.4K | ﹤0.01% | 1543 |
|
|
2016
Q1 | $1.02M | Sell |
68,166
-260
| -0.4% | -$4.36K | ﹤0.01% | 1784 |
|
|
2015
Q4 | $1.5M | Buy |
68,426
+5,240
| +8% | +$97.6K | ﹤0.01% | 1534 |
|
|
2015
Q3 | $996K | Buy |
63,186
+2,046
| +3% | +$32.8K | ﹤0.01% | 1765 |
|
|
2015
Q2 | $873K | Sell |
61,140
-1,950
| -3% | -$33K | ﹤0.01% | 1952 |
|
|
2015
Q1 | $1.09M | Buy |
63,090
+9,100
| +17% | +$161K | ﹤0.01% | 1807 |
|
|
2014
Q4 | $968K | Sell |
53,990
-2,475
| -4% | -$39.9K | ﹤0.01% | 1841 |
|
|
2014
Q3 | $741K | Sell |
56,465
-100
| -0.2% | -$1.35K | ﹤0.01% | 1965 |
|
|
2014
Q2 | $813K | Sell |
56,565
-854
| -1% | -$11.1K | ﹤0.01% | 1965 |
|
|
2014
Q1 | $732K | Sell |
57,419
-2,310
| -4% | -$30.1K | ﹤0.01% | 1992 |
|
|
2013
Q4 | $597K | Sell |
59,729
-2,270
| -4% | -$25.8K | ﹤0.01% | 2147 |
|
|
2013
Q3 | $816K | Buy |
61,999
+58
| +0.1% | +$761 | ﹤0.01% | 1904 |
|
|
2013
Q2 | $885K | Buy |
+61,941
| New | +$779K | ﹤0.01% | 1847 |
|
Other funds holding NXTM
RhumbLine Advisers's NXTM Position: Q1 2019 in Review
RhumbLine Advisers sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 92,310 shares — an estimated $2.64M sold.
RhumbLine Advisers first reported a position in NXTM in Q2 2013 and held it in 23 quarters. The position peaked at $2.64M in Q4 2018. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.
- RhumbLine Advisers reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
- RhumbLine Advisers sold 92,310 NxStage Medical Inc. shares in Q1 2019, an estimated $2.64M.
- RhumbLine Advisers first reported a position in NxStage Medical Inc. in Q2 2013 and held it in 23 quarters.
- RhumbLine Advisers's NxStage Medical Inc. position peaked at $2.64M in Q4 2018.
- 1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.
Based on RhumbLine Advisers's 13F filing for Q1 2019, filed 1 May 2019.